Surfing the MASH Tsunami

Surfing the MASH Tsunami

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(1073)

S3-E46.6 - From the Vault: Can Weight Loss From GLP-1s or Double/Triple Agonists Emulate the Effects of Bariatric Surgery in SPLENDOR?

S3-E46.6 - From the Vault: Can Weight Loss From GLP-1s or Double/Triple Agonists Emulate the Effects of Bariatric Surgery in SPLENDOR?

Send us Fan Mail The 2022 NAFLD Summit presented a range of perspectives and insights on fatty liver and metabolic diseases. In Season 3, Episode 46, program speakers Mazen Noureddin, Sven Francque an...

25 Sep 202211min

S3-E46.5 - Discussing NITs and Final Thoughts on NAFLD Summit

S3-E46.5 - Discussing NITs and Final Thoughts on NAFLD Summit

Send us Fan Mail The 2022 NAFLD Summit presented a range of perspectives and insights on fatty liver and metabolic diseases. Program speakers Mazen Noureddin, Sven Francque and Hannes Hagström join Su...

25 Sep 202216min

S3-E46.4 - Weight Change and Lifestyle Modification in Clinical Trials

S3-E46.4 - Weight Change and Lifestyle Modification in Clinical Trials

Send us Fan Mail The 2022 NAFLD Summit presented a range of perspectives and insights on fatty liver and metabolic diseases. Program speakers Mazen Noureddin, Sven Francque and Hannes Hagström join Ro...

25 Sep 20226min

S3 E46.3 - Discussing Clinical Trial Design at the NAFLD Summit

S3 E46.3 - Discussing Clinical Trial Design at the NAFLD Summit

Send us Fan Mail The 2022 NAFLD Summit presented a range of perspectives and insights on fatty liver and metabolic diseases. In this conversation, the panelists explore issues around clinical trial de...

24 Sep 202210min

S3-E46.2 - NAFLD Summit in Context and Learning from Failed Trials

S3-E46.2 - NAFLD Summit in Context and Learning from Failed Trials

Send us Fan Mail The 2022 NAFLD Summit uniquely presented a range of perspectives and insights on fatty liver and metabolic diseases. Program speakers Mazen Noureddin, Sven Francque and Hannes Hagströ...

24 Sep 202212min

S3-E46.1 - Underreported Alcohol Use and Treating Comorbidities

S3-E46.1 - Underreported Alcohol Use and Treating Comorbidities

Send us Fan Mail The 2022 NAFLD Summit presented a range of perspectives and insights on fatty liver and metabolic diseases. Program speakers Mazen Noureddin, Sven Francque and Hannes Hagström join Su...

24 Sep 202212min

S3-E46 - A Review of the 2022 NAFLD Summit from Dublin

S3-E46 - A Review of the 2022 NAFLD Summit from Dublin

Send us Fan Mail The 2022 NAFLD Summit presented a range of perspectives and insights on fatty liver and metabolic diseases. In this episode, program speakers Mazen Noureddin, Sven Francque and Hannes...

22 Sep 202255min

S3-E45.5 - From the Vault: What Can NAIL-NIT Retrospective Analysis Tell Us About NASH?

S3-E45.5 - From the Vault: What Can NAIL-NIT Retrospective Analysis Tell Us About NASH?

Send us Fan Mail In Season 3, Episode 19, the content focus looks at what the retrospective analysis from the NAIL-NIT consortium can achieve in terms of moving the shift beyond the biopsy in NASH dia...

20 Sep 202212min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
rekommandert
liberal-halvtime
sinnsyn
dekodet-2
forskningno
fjellsportpodden
villmarksliv
tomprat-med-gunnar-tjomlid
abels-tarn
rss-overskuddsliv
rss-lundqvist-podden
rss-nysgjerrige-norge
rss-paradigmepodden
rss-rekommandert
kvinnehelsepodden
grunnstoffene
hva-er-greia-med